TY - JOUR
T1 - Identification of Fusobacterium Species Using Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry by Updating ASTA CoreDB
AU - Yun, Shin Young
AU - Lee, Yunhee
AU - Hong, Juwon
AU - Kim, Dong Chan
AU - Lee, Hyukmin
AU - Yong, Dongeun
AU - Lim, Yun Kyong
AU - Kook, Joong Ki
AU - Lee, Kyungwon
N1 - Publisher Copyright:
© Yonsei University College of Medicine 2022.
PY - 2022/12
Y1 - 2022/12
N2 - Purpose: Fusobacterium species can cause infections, and associations with cancer are being increasingly reported. As their clinical significance differs, accurate identification of individual species is important. However, matrix-assisted laser desorption/ion-ization-time of flight mass spectrometry has not been found to be effective in identifying Fusobacterium species in previous stud-ies. In this study, we aimed to improve the accuracy and efficacy of identifying Fusobacterium species in clinical laboratories. Materials and Methods: In total, 229 Fusobacterium isolates were included in this study. All isolates were identified at the species level based on nucleotide sequences of the 16S ribosomal RNA gene and/or DNA-dependent RNA polymerase β-subunit gene (rpoB). Where necessary, isolates were identified based on whole genome sequences. Among them, 47 isolates were used for updating the ASTA database, and 182 isolates were used for the validation of Fusobacterium spp. identification. Results: Fusobacterium isolates used for validation (182/182) were correctly identified at the genus level, and most (180/182) were correctly identified at the species level using the ASTA MicroIDSys system. Most of the F. nucleatum isolates (74/75) were correctly identified at the subspecies level. Conclusion: The updated ASTA MicroIDSys system can identify nine species of Fusobacterium and four subspecies of F. nuclea-tum in good agreement. This tool can be routinely used in clinical microbiology laboratories to identify Fusobacterium species and serve as a springboard for future research.
AB - Purpose: Fusobacterium species can cause infections, and associations with cancer are being increasingly reported. As their clinical significance differs, accurate identification of individual species is important. However, matrix-assisted laser desorption/ion-ization-time of flight mass spectrometry has not been found to be effective in identifying Fusobacterium species in previous stud-ies. In this study, we aimed to improve the accuracy and efficacy of identifying Fusobacterium species in clinical laboratories. Materials and Methods: In total, 229 Fusobacterium isolates were included in this study. All isolates were identified at the species level based on nucleotide sequences of the 16S ribosomal RNA gene and/or DNA-dependent RNA polymerase β-subunit gene (rpoB). Where necessary, isolates were identified based on whole genome sequences. Among them, 47 isolates were used for updating the ASTA database, and 182 isolates were used for the validation of Fusobacterium spp. identification. Results: Fusobacterium isolates used for validation (182/182) were correctly identified at the genus level, and most (180/182) were correctly identified at the species level using the ASTA MicroIDSys system. Most of the F. nucleatum isolates (74/75) were correctly identified at the subspecies level. Conclusion: The updated ASTA MicroIDSys system can identify nine species of Fusobacterium and four subspecies of F. nuclea-tum in good agreement. This tool can be routinely used in clinical microbiology laboratories to identify Fusobacterium species and serve as a springboard for future research.
UR - http://www.scopus.com/inward/record.url?scp=85142614240&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142614240&partnerID=8YFLogxK
U2 - 10.3349/ymj.2022.0271
DO - 10.3349/ymj.2022.0271
M3 - Article
C2 - 36444550
AN - SCOPUS:85142614240
SN - 0513-5796
VL - 63
SP - 1138
EP - 1143
JO - Yonsei medical journal
JF - Yonsei medical journal
IS - 12
ER -